In addition to the many published studies on microcurrent therapy, ARC Microtech have collaborated with the University of Greenwich to explore the clinical applications of the Arc4Health. To date, three research studies have been published in the European Journal of Applied Physiology and the European Journal of Sport Science. Please find the abstracts below.
Published in the European Journal of Applied Physiology (November 2022)
Stefan Kolimechkov, Marcos Seijo, Ian Swaine, Jack Thirkell, Juan C. Colado and Fernando Naclerio
Abstract
Microcurrent is a non-invasive and safe electrotherapy applied through a series of sub-sensory electrical currents (less than 1 mA), which are of a similar magnitude to the currents generated endogenously by the human body. This review focuses on examining the physiological mechanisms mediating the effects of microcurrent when combined with different exercise modalities (e.g. endurance and strength) in healthy physically active individuals. The reviewed literature suggests the following candidate mechanisms could be involved in enhancing the effects of exercise when combined with microcurrent: (i) increased adenosine triphosphate resynthesis, (ii) maintenance of intercellular calcium homeostasis that in turn optimises exercise-induced structural and morphological adaptations, (iii) eliciting a hormone-like effect, which increases catecholamine secretion that in turn enhances exercise-induced lipolysis and (iv) enhanced muscle protein synthesis. In healthy individuals, despite a lack of standardisation on how microcurrent is combined with exercise (e.g. whether the microcurrent is pulsed or continuous), there is evidence concerning its effects in promoting body fat reduction, skeletal muscle remodelling and growth as well as attenuating delayed-onset muscle soreness. The greatest hindrance to understanding the combined effects of microcurrent and exercise is the variability of the implemented protocols, which adds further challenges to identifying the mechanisms, optimal patterns of current(s) and methodology of application. Future studies should standardise microcurrent protocols by accurately describing the used current [e.g. intensity (μA), frequency (Hz), application time (minutes) and treatment duration (e.g. weeks)] for specific exercise outcomes, e.g. strength and power, endurance, and gaining muscle mass or reducing body fat.
For full published paper please contact us.
Published in the European Journal of Sport Science (February 2021)
Fernando Naclerio, Diego Moreno-Perez, Marcos Seijo, Bettina Karsten, Mar Larrosa, Jose Ánge L. García-Merino, Jack Thirkell and Eneko Larumbe-Zabala
Abstract
Post-exercise microcurrent based treatments have shown to optimise exercise-induced adaptations in athletes. We compared the effects of endurance training in combination with either, a microcurrent or a sham treatment, on endurance performance. Additionally, changes in body composition, post-exercise lactate kinetics and perceived delayed onset of muscle soreness (DOMS) were determined. Eighteen males (32.8 ± 6.3 years) completed an 8-week endurance training programme involving 5 to 6 workouts per week wearing a microcurrent (MIC, n=9) or a sham (SH, n=9) device for 3-h post-workout or in the morning during non-training days. Measurements were conducted at pre- and post-intervention. Compared to baseline, both groups increased (P < 0.01) maximal aerobic speed (MIC, pre = 17.6 ± 1.3 to post=18.3 ± 1.0; SH, pre=17.8 ± 1.5 to post = 18.3 ± 1.3 km.h−1) with no changes in V˙V˙O2peak. No interaction effect per group and time was observed (P=0.193). Although both groups increased (P < 0.05) trunk lean mass (MIC, pre=23.2 ± 2.7 to post=24.2 ± 2.0; SH, pre=23.4 ± 1.7 to post=24.3 ± 1.6 kg) only MIC decreased (pre=4.8 ± 1.5 to post=4.5 ± 1.5, p=0.029) lower body fat. At post-intervention, no main differences between groups were observed for lactate kinetics over the 5 min recovery period. Only MIC decreased (P<0.05) DOMS at 24-h and 48-h, showing a significant average lower DOMS score over 72-h after the completion of the exercise-induced muscle soreness protocol. In conclusion, a 3-h daily application of microcurrent over an 8-week endurance training programme produced no further benefits on performance in endurance-trained males. Nonetheless, the post-workout microcurrent application promoted more desirable changes in body composition and attenuated the perception of DOMS over 72-h post-exercise.
For full published paper please contact us.
Published in the European Journal of Applied Physiology (October 2019)
Fernando Naclerio, Marcos Seijo, Bettina Karsten, George Brooker, Leandro Carbone, Jack Thirkell and Eneko Larumbe-Zabala
Abstract
Microcurrent has been used to promote tissue healing after injury or to hasten muscle remodeling post exercise. The purpose of this study was to compare the effects of resistance training in combination with either, microcurrent or sham treatment, on-body composition and muscular architecture. Additionally, changes in performance and perceived delayed onset muscle soreness (DOMS) were determined. Eighteen males (25.7 ± 7.6 years) completed an 8-week resistance training program involving 3 workouts per week (24 total sessions) wearing a microcurrent (MIC, n = 9) or a sham (SH, n = 9) device for 3-h post-workout or in the morning during non-training days. Measurements were conducted at pre and post intervention. Compared to baseline, both groups increased (p < 0.05) muscle thickness of the elbow flexors (MIC + 2.9 ± 1.4 mm; SH + 3.0 ± 2.4 mm), triceps brachialis (MIC + 4.3 ± 2.8 mm; SH + 2.7 ± 2.6 mm), vastus medialis (MIC + 1.5 ± 1.5 mm; SH + 0.9 ± 0.8 mm) and vastus lateralis (MIC + 6.8 ± 8.0 mm; SH + 3.2 ± 1.8 mm). Although both groups increased (p < 0.01) the pennation angle of vastus lateralis (MIC + 2.90° ± 0.95°; SH + 1.90° ± 1.35°, p < 0.01), the change measured in MIC was higher (p = 0.045) than that observed in SH. Furthermore, only MIC enlarged (p < 0.01) the pennation angle of brachialis (MIC + 1.93 ± 1.51). Both groups improved (p < 0.05) bench press strength and power but only MIC enhanced (p < 0.01) vertical jump height. At post intervention, only MIC decreased (p < 0.05) DOMS at 12-h, 24-h, and 48-h after performing an exercise-induced muscle soreness protocol. A 3-h daily use of microcurrent maximized muscular architectural changes and attenuated DOMS with no added significant benefits on body composition and performance.
For full published paper please contact us.
Website news!
Great news! We have recently merged our websites, meaning customers worldwide are now able to access our full website. Please note, the Arc4Health is a Class IIa medical device, regulated in the UK and Europe. Should you wish to purchase the Arc4Health outside of the UK and Europe, at checkout you will need to confirm that you understand that it is only regulated within these 33 countries.
Any queries we are always happy to help, get in touch on admin@arcmicrotech.com